Altasciences’ Chris Perkin Honored as One of 100 Most Inspiring Leaders in the Life Sciences Industry
LAVAL, QC, Canada (August 8, 2017) — Altasciences Clinical Research, one of the largest early phase Clinical Research Organizations (CROs) in North America, is pleased to announce that Chris Perkin, Chief Executive Officer, has been named one of the 100 Most Inspiring Leaders in the Life Sciences Industry by PharmaVOICE magazine for a third consecutive year — an honor bestowed on individuals recognized for the positive impact they have had on the industry through their leadership, influence and positive actions.
Mr. Perkin has been in the industry for more than 40 years, and with his experience and strategic leadership, has brought Altasciences to new heights since joining the company in 2010. He was nominated by his peers and employees for being an exemplary and inspirational corporate leader, whose guidance, dedication, and drive to innovate have contributed to the advancement of clinical trials and ensure the continued success of Altasciences.
When asked how he felt about his third consecutive award, Chris replied “It is always such an honor to receive this recognition because I get to share it with the people that feel as passionately as I do about our business and contribute to our success day in and day out, our staff. They are the ones that challenge the everyday standard, bring to life our vision and drive the company’s growth by achieving scientific breakthroughs and saving lives. We truly bring out the best in each other.”
About Altasciences Clinical Research
Altasciences Clinical Research encompasses Algorithme Pharma in Montreal, QC, Vince & Associates Clinical Research in Overland Park, KS, as well as Algorithme Pharma USA in Fargo, ND, thereby making it one of the largest early phase clinical CROs in North America. With over 25 years of industry experience, Altasciences provides early phase clinical development services to an international customer base of biopharmaceutical and generic companies. Altasciences’ full-service solutions offering in this critical stage of drug development includes medical writing, biostatistics, data management and bioanalysis.
For More Information
Director, Communications and Marketing
Our deep expertise and capabilities in a broad range of therapeutic areas encompasses preclinical and early clinical studies for both small molecules and biologics. We can manage your entire program, as well as provide support research services and bioanalytical expertise.
Please see Therapeutic Areas for a fuller discussion of our capabilities and expertise.